lopinavir (Kaletra) Report issue

Small molecule Approved FDA Fast Track FDA Accelerated Approval FDA Priority Review FDA

Active Ingredient History

  • Now
Lopinavir (ABT-378) is an antiretroviral of the protease inhibitor class. It is used against HIV infections as a fixed-dose combination with another protease inhibitor, ritonavir, under the trade names Kaletra.   NCATS

  • Mol. Mass: 628.8008
  • ALogP: 4.33
  • ChEMBL Molecule:
More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Oral
  • Pro Drug: No

Combination drugs

( ritonavir (Norvir), lopinavir (Kaletra) - other names: lopinavir: ritonavir, lopinavir/ritonavir )
a-157378-0 | a-157378.0 | abt-378 | aluvia | aluviran | kaletra | koletra | lopimune | lopinavir | lopinavir mixture with ritonavir | lopinavir / ritonavir | lopinavir/ritonavir | lopinavir-ritonavir drug combination | lpv


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue